Cargando…

Efficacy and Safety of Once Daily Fluticasone Furoate Nasal Spray for Treatment of Irritant (Non-allergic) Rhinitis

INTRODUCTION: The safety and efficacy of fluticasone furoate nasal spray (FFNS) for the symptoms of seasonal and perennial allergic rhinitis have been previously demonstrated in several clinical studies. The objective of this pilot study was to compare the efficacy and safety of FFNS 110 mcg once da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tantilipikorn, Pongsakorn, Thanaviratananich, Sanguansak, Chusakul, Supinda, Benjaponpitak, Suwat, Fooanant, Supranee, Chintrakarn, Chalermchai, Jirapongsananuruk, Orathai, Visitsunthorn, Nualanong, Toler, Tom, Sutton, Laura, Wu, Wei, Lee, Laurie
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023068/ https://www.ncbi.nlm.nih.gov/pubmed/21253453 http://dx.doi.org/10.2174/1874306401004010092

Ejemplares similares

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
por: O’Byrne, Paul M., et al.
Publicado: (2014)

Carrying rates of epinephrine devices in children with food-induced anaphylaxis
por: Ratanaprug, Chanonart, et al.
Publicado: (2019)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
por: Kariyawasam, Harsha H, et al.
Publicado: (2010)

Fluticasone furoate nasal spray in the treatment of allergic rhinitis
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2008)

Successful wheat-specific oral immunotherapy in highly sensitive individuals with a novel multirush/maintenance regimen
por: Pacharn, Punchama, et al.
Publicado: (2014)

The Effect of Vitamin D Status on Pediatric Asthma at a University Hospital, Thailand
por: Krobtrakulchai, Wijittra, et al.
Publicado: (2013)

Defining Biomarkers to Predict Natural Resolution in Shrimp Allergy
por: Piboonpocanun, Surapon, et al.
Publicado: (2022)

A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Intranasal fluticasone furoate in pediatric allergic rhinitis: randomized controlled study
por: Zhang, Yamei, et al.
Publicado: (2020)

149 Once Daily Intranasal Fluticasone Furoate Decreases Daytime Sleepiness and Improves Cognitive Performance in Symptomatic Seasonal Allergic Rhinitis
por: Diaz, Alejandro
Publicado: (2012)

The Complications of Sinusitis in a Tertiary Care Hospital: Types, Patient Characteristics, and Outcomes
por: Chaiyasate, Saisawat, et al.
Publicado: (2015)

Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma
por: O’Byrne, Paul M., et al.
Publicado: (2016)

The Utility of Serum Tryptase in the Diagnosis of Food-Induced Anaphylaxis
por: Wongkaewpothong, Patcharaporn, et al.
Publicado: (2014)

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)

Fluticasone furoate/fluticasone propionate – different drugs with different properties
por: Biggadike, Keith
Publicado: (2011)

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial
por: Woodcock, Ashley, et al.
Publicado: (2011)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
por: Woodcock, Ashley, et al.
Publicado: (2011)

Fluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis
por: Anolik, Robert
Publicado: (2010)

Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
por: Chennakeshavaraju, Nandish, et al.
Publicado: (2020)

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy
por: Albertson, Timothy E, et al.
Publicado: (2016)

Erratum: “Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis”
Publicado: (2021)

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
por: Bateman, Eric D, et al.
Publicado: (2014)

Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design
por: Worsley, Sally, et al.
Publicado: (2019)

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database
por: Atsuta, Ryo, et al.
Publicado: (2018)

Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19
por: Boulware, David R., et al.
Publicado: (2023)

Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
por: Atipas, Kawita, et al.
Publicado: (2022)

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial
por: O’Byrne, Paul M, et al.
Publicado: (2014)

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial
por: Busse, W W, et al.
Publicado: (2014)

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy
por: Svedsater, Henrik, et al.
Publicado: (2016)

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD
por: Bhatt, Surya P, et al.
Publicado: (2017)

Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
por: Zhang, Nan, et al.
Publicado: (2014)

The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression
por: Allen, Ann
Publicado: (2013)

Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate/Vilanterol in Healthy Chinese Subjects
por: Chen, Xia, et al.
Publicado: (2015)

Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 µG Versus Twice-Daily Fluticasone Propionate 250 µG in Adolescents and Adults with Persistent Asthma
por: Tomlinson, Ryan, et al.
Publicado: (2017)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination
por: Oliver, A, et al.
Publicado: (2013)

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
por: Day, Nicola C., et al.
Publicado: (2020)

Pattern of Aeroallergen Sensitization and Quality of Life in Adult Thai Patients With Allergic Rhinitis
por: Katel, Puspalal, et al.
Publicado: (2021)

Effect of once-daily fluticasone furoate/vilanterol versus vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial
por: Maltais, Francois, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_00t7eq2r7jug7ol13r73hpltsa